The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2018 | Aiming for the NOLCP in Wales and HCP collaboration
This years’ British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, presented a range of exciting data, with talks on a National Optimal Lung Cancer Pathway (NOLCP) for the UK a hot topic. Speaking from the meeting, Sarah Morgan, of Hywel Dda University Health Board, Carmarthen, UK, gives us her high points from the meeting. She highlights information on the NOLCP, commenting on lung cancer care in Wales, as well as the collaborative research which the meeting fosters.
